Literature DB >> 8483863

Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches.

J Nørregaard1, P Tønnesen, L Petersen.   

Abstract

BACKGROUND: The reasons for relapse to smoking are not fully understood but several factors are of importance. Addiction to nicotine seems to play a prominent role but there are several other contributing factors.
METHODS: To determine predictors of outcome in smoking cessation, we performed univariate and multivariate analyses in a large smoking cessation trial comprising 289 subjects. Weight gain and withdrawal symptoms were analyzed separately as predictors. To determine self-perceived reasons for relapse we created a questionnaire, which was answered by 132 relapsers.
RESULTS: Previous attempts to quit smoking and a low saliva cotinine concentration were significantly associated with abstinence in the nicotine-treated group. A trend toward higher abstinence rates was found among males and among subjects with a low nicotine dependency score. Logistic regression analysis showed higher success rates in subjects with the largest weight gain during the first weeks of quitting in contrast to higher relapse rates in subjects who had the greatest weight gain after 3 months. A high score on withdrawal symptoms was not predictive of relapse. Subjects with "slips" had a markedly increased relapse rate. Craving for cigarettes was the most often self-reported (48%) reason for relapse.
CONCLUSIONS: The relation between weight gain, withdrawal scoring, and outcome seems rather complex. Craving for cigarettes was the most reported reason for relapse.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8483863     DOI: 10.1006/pmed.1993.1021

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  32 in total

1.  Open randomised trial of intermittent very low energy diet together with nicotine gum for stopping smoking in women who gained weight in previous attempts to quit.

Authors:  T Danielsson; S Rössner; A Westin
Journal:  BMJ       Date:  1999-08-21

2.  Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.

Authors:  Karen L Skjei; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2003-04-24       Impact factor: 4.530

3.  Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender.

Authors:  Sarah E Evans; Melissa Blank; Cynthia Sams; Michael F Weaver; Thomas Eissenberg
Journal:  Exp Clin Psychopharmacol       Date:  2006-05       Impact factor: 3.157

Review 4.  Distress tolerance and early smoking lapse.

Authors:  Richard A Brown; C W Lejuez; Christopher W Kahler; David R Strong; Michael J Zvolensky
Journal:  Clin Psychol Rev       Date:  2005-09

5.  Does nicotine withdrawal affect smoking cessation? Clinical and theoretical issues.

Authors:  C A Patten; J E Martin
Journal:  Ann Behav Med       Date:  1996-09

6.  Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial.

Authors:  Arthur L Brody; Alexey G Mukhin; Michael S Mamoun; Trinh Luu; Meaghan Neary; Lidia Liang; Jennifer Shieh; Catherine A Sugar; Jed E Rose; Mark A Mandelkern
Journal:  JAMA Psychiatry       Date:  2014-07-01       Impact factor: 21.596

7.  Randomized trial comparing mindfulness training for smokers to a matched control.

Authors:  James M Davis; Alison R Manley; Simon B Goldberg; Stevens S Smith; Douglas E Jorenby
Journal:  J Subst Abuse Treat       Date:  2014-05-02

8.  Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment.

Authors:  S G Gourlay; N L Benowitz; A Forbes; J J McNeil
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

9.  Predictors of success in a smoking cessation clinic.

Authors:  S E Sherman; M M Wang; B Nguyen
Journal:  J Gen Intern Med       Date:  1996-11       Impact factor: 5.128

Review 10.  Developing human laboratory models of smoking lapse behavior for medication screening.

Authors:  Sherry A McKee
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.